Foghorn Therapeutics
Salih Topal is a seasoned bioinformatics expert currently serving as a Senior Scientist at Foghorn Therapeutics, Inc., since November 2020. With a robust background in molecular biology, Salih was previously a Global Talent Fellow at Open Avenues and held significant roles at the University of Massachusetts Medical School, including Postdoctoral Associate and Graduate Research Assistant. Research expertise includes the regulation of eukaryotic transcription by chromatin remodelers and the application of next-generation sequencing techniques. Academic credentials feature a PhD in Molecular Biology from UMass Chan Medical School, a Master’s Degree in Developmental Neuroscience from the University of Strasbourg, and a BSc in Molecular Biology and Genetics from Istanbul Technical University. Salih has also contributed to research at Boston Children's Hospital and various institutions in France and Turkey.
This person is not in any teams
This person is not in any offices
Foghorn Therapeutics
1 followers
Foghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention. Their proprietary Gene Traffic Control platform gives them an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing them to identify, validate, and potential drug targets within the system.